Comparison of Serum and Salivary Antioxidants in Patients with Temporomandibular Joint Disorders and Healthy Subjects

Shirin Lawaf, Arash Azizi, Tohid Tabarestani, Shirin Lawaf, Arash Azizi, Tohid Tabarestani

Abstract

Objectives: Temporomandibular dysfunction (TMD) is a group of disorders in the facial region and temporomandibular joint (TMJ). Biomarkers are assumed to play a role in pain and early detection of destruction. The aim of this study was to compare the saliva and serum antioxidant levels in patients with TMD and healthy subjects.

Materials and methods: This case-control study was conducted on 28 TMD patients without pain, 28 TMD patients with pain and 28 healthy controls. The total antioxidant capacity of saliva and serum of patients was measured. Data were analyzed using ANOVA and Tamhane's test.

Results: The mean (±SD) total antioxidant capacity of serum (plasma TAC) was 0.8900 (±0.11627) mmol/L in TMD patients with pain, 1.2717 (±0.18711) mmol/L in TMD patients without pain and 1.7500(±0.18711) mmol/L in the control group. Based on ANOVA, the difference in this regard among the three groups was statistically significant (P=0.000). The mean salivary TAC was 1.34 (±0.06721) mmol/L in TMD patients with pain, 1.42 (±0.16677) mmol/L in TMD patients without pain and 1.35 (±0.11627) mmol/L in the control group. The difference in this respect among the three groups was not significant (P>0.05).

Conclusion: The mean plasma TAC in TMD patients with/without pain was significantly lower than that in the control group but no significant difference was detected in salivary TAC among the three groups.

Keywords: Antioxidants; Oxidative Stress; Saliva; Serum; Temporomandibular Joint Disorders.

References

    1. Al-Belasy F, Dolwick M. Arthrocentesis for the treatment of temporomandibular joint closed lock: a review article. Int J Oral Maxillofac Surg. 2007September; 36 ( 9): 773– 82.
    1. Ueno T, Yamada M, Sugita Y, Ogawa T. Acetyl cysteine protects TMJ chondrocytes from oxidative stress. J Dent Res 2011. March; 90 ( 3): 353– 9.
    1. Richards RS, Roberts TK, McGregor NR, Dustan RH, Butt HL. Blood parameters indicative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep 2000; 5 ( 1): 35– 41.
    1. Halliwell B, Gutteridge JM. Free radicals in biology and medicine ; 1st Ed; Oxford University ; 2007 : 112 – 118 .
    1. Slavish DC, Graham-Engeland JE, Smyth JM, Engeland CG. Salivary markers of inflammation in responce to acute stress. Brain Behav Immun 2015. February; 44: 253– 69.
    1. Sheets DW, Jr , Okamoto T, Dijkgraaf LC, Milam SB, Schmitz JP, Zardeneta G. Free radical damage in facsimile synovium: correlation with adhesion formation in osteoarthritic TMJs. J Prosthodont 2006. Jan-Feb; 15 ( 1): 9– 19.
    1. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990; 186: 421– 31.
    1. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr. 2000. February; 71 ( 2): 621S– 629S.
    1. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol. 2006. July; 65 ( 7): 631– 41.
    1. Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther. 2004; 6 ( 6): 265– 78.
    1. Azizi A, Farshchi F. Comparison of salivary and plasma antioxidant between lichen planus patients and healthy subjects. J Oral Pathol Med. 2012. August; 41 ( 7): 524– 6.
    1. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39 ( 1): 44– 84.
    1. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006. Dec 14 ; 444 ( 7121): 875– 80.
    1. Khan MA, Chen HC, Wan XX, Tania M, Xu AH, Chen FZ, et al. Regulatory effects of resveratrol on antioxidant enzymes: A mechanism of growth inhibition and apoptosis induction in cancer cells. Mol Cells. 2013. March; 35 ( 3): 219– 25.
    1. Kaneyama K, Segami N, Sato J, Yoshimura H, Nishiura R. Expression of receptor activator of nuclear factor-kappaB ligand in synovial tissue: comparison with degradation of articular cartilage in temporomandibular joint disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007. August; 104 ( 2): e12– 7.
    1. Wang XD, Kou XX, Mao JJ, Gan YH, Zhou YH. Sustained inflammation induces degeneration of the temporomandibular joint. J Dent Res 2012. May; 91 ( 5): 499– 505.
    1. Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yildizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int. 2006. May; 26 ( 7): 598– 603.
    1. Rodriguez de Sotillo D, Velly AM, Hadley M, Fricton JR. Evidence of oxidative stress in temporomandibular disorders: a pilot study. J Oral Rehabil. 2011. October; 38 ( 10): 722– 8.
    1. Canakci CF, Cicek Y, Yildirim A, Sezer U, Canakci V. Increased levels of 8-hydroxydeoxyguanosine and malondialdehyde and its relationship with antioxidant enzymes in saliva of periodontitis patients. Eur J Dent. 2009. April; 3 ( 2): 100– 6.
    1. Shillinburg HT, Sather DA, Wilson EL. Fundamentals of fixed prosthodontics , Chicago, IL , Quintessence publishing , 2012 : 6 – 7 .
    1. Abu-Hilal M, McPhail MJ, Marchand L, Johnson CD. Malondialdehyde and superoxide dismutase as potential markers of severity in acute pancreatitis. JOP. 2006. Mar 9 ; 7 ( 2): 185– 92.
    1. Krupa W, Rozwodowska M, Sielski S, Czarnecka-Zaba E, Fabiszak T, Drewa G, et al. Influence of cardiac resynchronization therapy on oxidative stress markers in patients with chronic heart failure. Cardiol J. 2014; 21 ( 5): 576– 82.
    1. Chi CH, Shiesh SC, Lin XZ. Total antioxidant capacity and malondialdehyde in acute abdominal pain. Am J Emerg Med. 2002. Mar ; 20 ( 2): 79– 82.
    1. Cai HX, Luo JM, Long X, Li XD, Cheng Y. Free-radical oxidation and superoxide dismutase activity in synovial fluid of patients with temporomandibular disorders. J Orofac Pain. 2006. Winter; 20 ( 1): 53– 8.
    1. Güven O, Tekin US, Durak I, Keller EE, Hatipoglu M. Superoxide dismutase activity in synovial fluids in patients with temporomandibular joint internal derangement. J Oral Maxillofac Surg. 2007. October; 65 ( 10): 1940– 3.
    1. Tomida M, Ishimaru JI, Murayama K, Kajimoto T, Kurachi M, Era S, et al. Intra-articular oxidative state correlated with the pathogenesis of disorders of the temporomandibular joint. Br J Oral Maxillofac Surg. 2004. October; 42 ( 5): 405– 9.
    1. Etoz OA, Ataoglu H, Erel O, Celik H, Herken EN, Bayazit YA. Association of serum total antioxidant capacity and total oxidant status with pain perception in patients with myofacial pain dysfunction. Int J Neurosci. 2009; 119 ( 9): 1282– 91.
    1. Stark TR, Perez CV, Okeson JP. Recurrent TMJ Dislocation managed with Botulinum Toxin Type A infections in a pediatric patient. Pediatr Dent 2015; 37 ( 1): 65– 9.
    1. Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B, et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A. 2007. Aug 14 ; 104 ( 33): 13519– 24.
    1. Bouloux GF. Temporomandibular joint pain and synovial fluid analysis: a review of the literature. J Oral Maxillofac Surg. 2009. November; 67 ( 11): 2497– 504.
    1. Lee MC, Kawai Y, Shoji H, Yoshino F, Miyazaki H, Kato H, et al. Evidence of reactive oxygen species generation in synovial fluid from patients with temporomandibular disease by electron spin resonance spectroscopy. Redox Rep 2004; 9 ( 6): 331– 6.
    1. Alok S, Jain SK, Verma A, Kumar M, Mahor A, Sabharwal M. Herbal antioxidant in Clinical practice: a review. Asian Pac J Trop Biomed 2014. January; 4 ( 1): 78– 84.
    1. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 2001. June; 30 ( 11): 1191– 212.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever